Biogen, FDA’s inappropriate Aduhelm coordination detailed in blistering congressional report aarmstrong Thu, 12/29/2022 – 14:42 More: Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report Source: fierce
read moreAfter FDA’s Ukoniq pull, TG Therapeutics wins commercial mulligan with Briumvi to enter crowded MS arena fkansteiner Thu, 12/29/2022 – 09:30 More: After FDA's Ukoniq pull, TG Therapeutics wins commercial mulligan with Briumvi to enter crowded MS arena Source: fierce
read moreUCB’s bimekizumab finally back on the FDA’s review list after May rejection zbecker Wed, 12/28/2022 – 11:17 More: UCB's bimekizumab finally back on the FDA's review list after May rejection Source: fierce
read moreRoche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma kdunleavy Tue, 12/27/2022 – 09:16 More: Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma Source: fierce
read morePfizer, Sanofi settle first California Zantac case slated for trial: report zbecker Thu, 12/22/2022 – 12:38 More: Pfizer, Sanofi settle first California Zantac case slated for trial: report Source: fierce
read moreEditor’s corner: Fierce Pharma Manufacturing’s top 10 stories of 2022 fkansteiner Thu, 12/22/2022 – 09:36 More: Editor's corner: Fierce Pharma Manufacturing's top 10 stories of 2022 Source: fierce
read more© 1994 - 2024 B.M. Pharmaceuticals